NATCO PHARMA
|
NATCO PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
| Adjustment | ₹-22 Cr | ₹134 Cr | ₹102 Cr | ₹124 Cr | ₹62 Cr |
| Changes In working Capital | ₹-200 Cr | ₹-309 Cr | ₹63 Cr | ₹-231 Cr | ₹-213 Cr |
| Cash Flow after changes in Working Capital | ₹2,069 Cr | ₹1,498 Cr | ₹1,027 Cr | ₹95 Cr | ₹429 Cr |
| Cash Flow from Operating Activities | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr | ₹299 Cr |
| Cash Flow from Investing Activities | ₹-1,415 Cr | ₹-1,033 Cr | ₹-477 Cr | ₹-5.30 Cr | ₹-103 Cr |
| Cash Flow from Financing Activities | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr |
| Net Cash Inflow / Outflow | ₹72 Cr | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr | ₹9.80 Cr |
| Opening Cash & Cash Equivalents | ₹70 Cr | ₹132 Cr | ₹111 Cr | ₹26 Cr | ₹20 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-22 Cr | ₹6.50 Cr | ₹12 Cr | ₹9.30 Cr | ₹-3.80 Cr |
| Closing Cash & Cash Equivalent | ₹120 Cr | ₹70 Cr | ₹132 Cr | ₹111 Cr | ₹26 Cr |
Compare Cashflow Statement of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,922.5 Cr | 3% | 17.3% | 19.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3% |
17.3% |
19.1% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses